Back to results
US 2009/0275594 A1Published application
3-hydrazone piperazinyl rifamycin derivatives useful as antimicrobial agents
OwnerMark J. MACIELAG, Manomi Tennakooninventors
Life of this patent
Estimating the term…
Abstract
The present invention is directed to novel 3-hydrazone piperazinyl rifamycin derivatives, pharmaceutical compositions containing them and the use of said derivatives and pharmaceutical compositions as antimicrobial agents against pathogenic microorganisms, particularly against resistant microbes.
Claims15
A compound of formula (I)
- wherein
- Z is selected from the group consisting of
- R6 is selected from the group consisting of hydrogen and acyl;
- n is an integer from 0 to 1;
- Y is selected from the group consisting of C1-4alkyl and C2-6alkenyl;
- X is selected from the group consisting of R2
- R1 is selected from the group consisting of C1-4alkyl, —C1-4alkyl-OH, —C1-4alkyl-NRARB, aryl, heteroaryl, —CO2H and —CO2-C1-4alkyl;
- wherein the aryl is optionally substituted with one to two substituents independently selected from the group consisting of halogen, C1-4alkyl, C1-4alkoxy, halogenated C1-4alkyl, halogenated C1-4alkoxy, —NRC—C(O)—C1-4alkyl and —O—C1-4alkyl-NRCRD;
- and wherein RA, RB, RC and RD are each independently selected from the group consisting of hydrogen and C1-4alkyl;
- R2 is selected from the group consisting of hydrogen, —CO2H and —CO2—C1-4alkyl;
- R3 and R4 are each independently selected from the group consisting of hydrogen, halogen, C1-4alkyl, aryl, heteroaryl, —CO2H and —CO2-C1-4alkyl;
- R5 is selected from the group consisting of hydrogen, halogen, C1-4alkyl, aryl, heteroaryl, —CO2H and —CO2—C1-4alkyl;or a pharmaceutically acceptable salt, ester or prodrug thereof.
9 more elements
A compound selected from the group consisting of
- wherein
- (RIF1) is
- (RIF2) is
- R6 is —C(O)—CH3;
- and pharmaceutically acceptable salts, esters and prodrug thereof.
2 more elements
Dependencies are inferred from the claim text.